{"disease":{"id":"chronic-rhinosinusitis-phenotype-with-nasal-polyps-crswnp","name":"chronic rhinosinusitis phenotype with nasal polyps crswnp"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02898454","title":"Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":448,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT02912468","title":"A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":276,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT06892704","title":"Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Northwestern University","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}